The Library
Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesis
Tools
UNSPECIFIED (2003) Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesis. NATURAL PRODUCT REPORTS, 20 (2). pp. 252-273. doi:10.1039/b202149h
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://dx.doi.org/10.1039/b202149h
Abstract
The biosynthesis of peptidoglycan is essential for all bacteria and has no counterpart in eukaryotic cells. It is one of the prime targets for antibiotic chemotherapy, especially phospho-MurNAc-pentapeptide translocase (translocase I) is a fascinating target in which there is no commercial antibiotic. In this review we will describe three nucleoside translocase I inhibitors, mureidomycin, tunicamycin and liposidomycin.
Item Type: | Journal Item | ||||
---|---|---|---|---|---|
Subjects: | Q Science > QD Chemistry | ||||
Journal or Publication Title: | NATURAL PRODUCT REPORTS | ||||
Publisher: | ROYAL SOC CHEMISTRY | ||||
ISSN: | 0265-0568 | ||||
Official Date: | April 2003 | ||||
Dates: |
|
||||
Volume: | 20 | ||||
Number: | 2 | ||||
Number of Pages: | 22 | ||||
Page Range: | pp. 252-273 | ||||
DOI: | 10.1039/b202149h | ||||
Publication Status: | Published |
Data sourced from Thomson Reuters' Web of Knowledge
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |